Clinical Trials In Pennsylvania

Discover hundreds of clinical trials in Pennsylvania.
Search clinical trials in Pennsylvania by city, condition or phase.

e.g. Respiratory Diseases

Pennsylvania•Healthy volunteers: No

Filter results

Results: 3,026

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

West Reading, West Chester, Phoenixville, Meadowbrookshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)

Recruiting

Sponsor:

Rothman Institute Orthopaedics

Location:

Philadelphia

Code:

NCT01468129

Conditions

One-stage Bilateral Total Hip Replacement

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Cell Saver

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Recruiting

Phase 1

Phase 2

Sponsor:

Xentria, Inc.

Location:

Philadelphia, Birmingham, Denver, Jacksonvilleshow 12 more

Code:

NCT05890729

Conditions

Pulmonary Sarcoidosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

XTMAB-16 or Placebo

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Recruiting

Sponsor:

University of Pennsylvania

Location:

Philadelphia

Code:

NCT04323189

Conditions

Genetics Disease

Type2 Diabetes

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sitagliptin 100mg

Placebo Oral Tablet

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

Pittsburgh, Los Alamitos, San Diego, New Havenshow 20 more

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*

Recruiting

Sponsor:

Shriners Hospitals for Children

Location:

Philadelphia, Sacramento, Chicago, Lexingtonshow 4 more

Code:

NCT06305689

Conditions

Idiopathic Toe Walking

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Surgery

Serial Casting

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Recruiting

Phase 2

Sponsor:

Abramson Cancer Center at Penn Medicine

Location:

Philadelphia, Buffalo

Code:

NCT02153229

Conditions

Epitheliod Malignant Pleural Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Photodynamic Therapy

Radical Pleurectomy

Chemotherapy

Photofrin 2.0 mg/kg

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Recruiting

Sponsor:

Incyte Corporation

Location:

Pittsburgh, Fountain Valley, Long Beach, Washingtonshow 25 more

Code:

NCT05696392

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ruxolitinib cream

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Recruiting

Phase 2

Sponsor:

Taiho Oncology, Inc.

Location:

Horsham, Birmingham, Duarte, Huntington Beachshow 22 more

Code:

NCT05967689

Conditions

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAS6417

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Recruiting

Phase 1

Sponsor:

Abramson Cancer Center at Penn Medicine

Location:

Philadelphia

Code:

NCT03546829

Conditions

Early Stage Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vancomycin

Precision hypofractionated radiation

Popular cities in Pennsylvania

Philadelphia

e.g. Respiratory Diseases

Pennsylvania•Healthy volunteers: No

Filter results

Results: 3,026

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Recruiting

Sponsor:

NRG Oncology

Location:

West Reading, West Chester, Phoenixville, Meadowbrookshow 358 more

Code:

NCT05896189

Conditions

Breast Cancer

Cognitive Impairments

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Arm 1: Computerized Cognitive Training-Global Stimulation Games

Arm 2: Computerized Cognitive Training-Neuroplasticity Games

Cell Saver Use in Bilateral Total Hip Arthroplasty (THA)

Recruiting

Sponsor:

Rothman Institute Orthopaedics

Location:

Philadelphia

Code:

NCT01468129

Conditions

One-stage Bilateral Total Hip Replacement

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Cell Saver

A Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

Recruiting

Phase 1

Phase 2

Sponsor:

Xentria, Inc.

Location:

Philadelphia, Birmingham, Denver, Jacksonvilleshow 12 more

Code:

NCT05890729

Conditions

Pulmonary Sarcoidosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

XTMAB-16 or Placebo

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

Recruiting

Sponsor:

University of Pennsylvania

Location:

Philadelphia

Code:

NCT04323189

Conditions

Genetics Disease

Type2 Diabetes

Heart Failure

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sitagliptin 100mg

Placebo Oral Tablet

A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants

Recruiting

Phase 3

Sponsor:

Bristol-Myers Squibb

Location:

Pittsburgh, Los Alamitos, San Diego, New Havenshow 20 more

Code:

NCT06045689

Conditions

Myelodysplastic Syndromes

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Luspatercept

Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*

Recruiting

Sponsor:

Shriners Hospitals for Children

Location:

Philadelphia, Sacramento, Chicago, Lexingtonshow 4 more

Code:

NCT06305689

Conditions

Idiopathic Toe Walking

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Surgery

Serial Casting

Phase II Trial of Radical Pleurectomy With or Without Intraoperative PDT for Malignant Pleural Mesothelioma

Recruiting

Phase 2

Sponsor:

Abramson Cancer Center at Penn Medicine

Location:

Philadelphia, Buffalo

Code:

NCT02153229

Conditions

Epitheliod Malignant Pleural Mesothelioma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Photodynamic Therapy

Radical Pleurectomy

Chemotherapy

Photofrin 2.0 mg/kg

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Recruiting

Sponsor:

Incyte Corporation

Location:

Pittsburgh, Fountain Valley, Long Beach, Washingtonshow 25 more

Code:

NCT05696392

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ruxolitinib cream

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

Recruiting

Phase 2

Sponsor:

Taiho Oncology, Inc.

Location:

Horsham, Birmingham, Duarte, Huntington Beachshow 22 more

Code:

NCT05967689

Conditions

Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAS6417

Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer

Recruiting

Phase 1

Sponsor:

Abramson Cancer Center at Penn Medicine

Location:

Philadelphia

Code:

NCT03546829

Conditions

Early Stage Non-Small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vancomycin

Precision hypofractionated radiation